Drug Discovery moves to Stevenage – the new Golden Triangle hotspot?

19/04/2016 - 2 minutes

MRC Technology, a UK medical research charity, has moved most of its labs to the Stevenage Bioscience Catalyst (SBC) campus. Located inside the gold triangle, is this the new hotspot of UK Biotech?

mrc_technology_stevenage_bioscience_sbcMRC Technology provides drug discovery services, as well as advice for commercialisation and intellectual property management, for academia and industry.

Since it was founded in 2000, MRC Technology helped 18 startups and 12 drugs develop from research to the market – including Merck‘s cancer drug Keytruda and Takeda‘s Entyvio for Rheumatoid arthritis. It also generated over €800M (£630M) in royalties.

This research charity has now completed its move to Stevenage Bioscience Catalyst (SBC) campus, where it will have 2140 square meters of lab space and offices.

The move was announced back in 2013, and MRC Technology is to become the cornerstone tenant in SBC’s Accelerator building. Stevenage was apparently the right place to attract collaborations with universities, Biotechs and Pharma.

It is also becoming an increasingly important innovation hub in the UK Biotech scene –

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member